elililly

#EliLilly remains in focus as investors weigh how much growth is already priced into the stock.

Shares have returned more than 55% over the past year, far outpacing the broader market. Strong second-quarter results, with revenue up 48% and solid earnings growth, continue to support the bullish case, driven largely by Mounjaro and Zepbound.


The key question now is whether prescription momentum and manufacturing capacity can keep pace with elevated expectations. Upcoming data on volume growth, international expansion, and competitive dynamics will help determine if the premium valuation holds.

$LLYB $LLY $LLY.US #LLY #Stocks #Healthcare #CoinVahini

#elilillyrises5.3%torecordhigh
🚀 Eli Lilly ($LLY ) just hit a new all-time high.👀👀

The pharmaceutical giant reached $1,290 per share, pushing its market valuation to around $1.21 trillion and joining the trillion-dollar club.

The move highlights continued investor interest in major pharma companies and the broader weight-loss drug market.

For traders, the key areas to watch:
💊 Weight-loss drug demand
📈 $LLY momentum and valuation
🧬 Biotech & healthcare sentiment
🤖 AI-healthcare developments

For crypto traders, the bigger takeaway is how strongly capital continues to chase major growth themes across markets.

Can $LLY sustain its momentum after reaching another record high?

#LLY #EliLilly #Biotech #Healthcare #Trading

🚨 Eli Lilly Hits Record High!

Eli Lilly surged around 5.3%, pushing the pharmaceutical giant to a new record as investors piled into healthcare stocks.

The move comes amid renewed excitement around the drug sector and strong momentum surrounding Lilly's weight loss and diabetes portfolio.

💊 Healthcare is back in focus. 📈 Eli Lilly is breaking out. 🔥 Investors are watching the next move.
$LLY

#EliLilly #LLY #stocks #Healthcare #BİNANCE

ELI LILLY RAISES 2026 SALES GUIDANCE

Another corporate giant just upgraded its 2026 financial forecast! Pharma power Eli Lilly bumped its full-year sales outlook to a massive $85B–$87B following a strong Q2 earnings report. 🚀

Wait a second... does something feel disconnected here? 🧐 While many retail traders are struggling through market volatility and taking heavy losses, mega-cap corporations continue to report record-breaking revenues. Who is actually winning in this market environment? 😅

What’s your strategy for the pharma space right now—buying the dip on top healthcare stocks or staying on the sidelines until market conditions settle?

⚠️ Disclaimer: Not financial advice. Always conduct your own research.

👉 New users can sign up using referral code VINHTOCDO! 🚀

#Stocks #EliLilly #Crypto #Trading #VINHTOCDO $BTC
$ETH

#EliLillyRises5.3%ToRecordHigh Market Momentum
$LLY jumps 5.3% to a fresh record high, showing strong investor confidence and powerful momentum in the healthcare sector. Big moves like this can put major pharma stocks firmly on the market radar. 📈💊
#EliLilly
#LLY #Stocks #Healthcare #Market momentum #Investing

1st Stock Listing of the day...
$LLY
#EliLilly
Stock perpetual Contract is listing on Binance today shortly...
Listing Price Range: $1070 — $1115...

#elilillyraises2026salesoutlook
Another giant company raises its outlook for 2026! This time it’s the drug queen Eli Lilly (Eli Lilly), pumping out a massive $85–87 billion forecast after a strong performance in the second quarter. 🚀
Wait… does anyone else get a suspicious feeling here? 🧐 Traders are literally getting wiped out and living under a bridge, yet every big company prints historical revenues like it means nothing! Who actually wins in this game? 😅
What should individual traders do? Do they buy the drop in the healthcare/pharmaceutical sector, or stay safe and away from the arena?
⚠️ This is not financial advice.

Please follow.

#stocks #EliLilly #crypto #chamikametting
$BTC

LLY. Eli Lilly.
Market Update: Eli Lilly & Co. ($LLY )
Eli Lilly ($LLY ) closed the last session at $1,123.86, down -2.11% (-$24.34).
The Technical Setup: The daily candlestick chart shows $LLY pulling back from its peak around $1,292.65. The price action is currently hovering right near its 99-day Moving Average (MA99 at 1,112.65), which serves as a major dynamic support level on the daily timeframe.
Key Metrics: Even with the short-term pullback, Lilly commands a massive $1.02 Trillion market capitalization, trading at a P/E ratio of 38.35 with a robust trailing EPS of $29.97.
What to Watch: After-hours/overnight data shows minor stabilization attempts up +0.14% ($1,125.46). Traders are closely monitoring the MA(99) line—a clean bounce here could signal a continuation of its long-term bullish trend, while breaking beneath it might open up a deeper retracement toward the $1,080 psychological floor.
#Follow #BinanceSquare

#EliLilly #LLY #stockmarket

$LLY is showing a heavy bearish correction on the 4-hour chart, currently trading around 1,079.26 with a daily decline of -2.77%. Following a brief surge to its 24-hour high of 1,113.96, a massive wave of selling pressure triggered a sharp, vertical drop. The price is currently resting near its local lows after breaking significantly below its previous short-term structure, indicating intense distribution. Sellers remain firmly in control, and the market will look to see if the immediate 24-hour low at 1,071.50 can hold as reliable support to prevent further breakdown.
1,071.50
1,050.00
1,022.00
#LLY #EliLilly #TradFi

📊 LLYUSDT — Pullback After Strong Move?

$LLY (Eli Lilly Perpetual) is showing a mild correction after recent strength, currently trading around $1,082 with a slight bearish pressure on the day. 📉

📌 Market Snapshot 🔹 Last Price: ~$1,082.44
🔹 24H High: $1,113.96
🔹 24H Low: $1,075.53
🔹 Volume remains steady, showing active participation

💡 What’s happening? Price is currently cooling off after a strong push — a normal retracement phase within an active trend. Buyers are still defending lower levels, but momentum has slowed.

⚠️ Key Levels to Watch • Support: $1,075 – $1,080
• Major Support: $1,060
• Resistance: $1,110 – $1,115

🎯 Trading Insight ✔️ Pullbacks like this often reset momentum
✔️ Holding support = continuation potential
✔️ Losing support = deeper correction risk

Patience is key — let the structure confirm before reacting.

$LLYUSDT #EliLilly #Trading #CryptoFutures 📊🔥

$LLYon USDT is maintaining a strong market structure with steady buying momentum. A breakout could lead to another leg higher.
📍EP: 1215 – 1225
🎯TP1: 1245
🎯TP2: 1275
🎯TP3: 1300
🛑SL: 1190
💰 Strong trend + discipline = Consistent results.
#LLYUSDT #EliLilly #StocksOnCrypto

$LLYon

🙂LLYUSDT PUMPING +4.65%? $1,228.34 BREAKING!

Eli Lilly on FIRE! Everyone on the street is watching! 👀

*Price: $1,228.34 (+4.65%)*
📈 24H High: $1,234.89
📉 24H Low: $1,172.16
💰 Vol: 5.05M USDT

Today +1.33% | 7D +2.71% | 30D +7.54%

LLY Spot: $1,227.575 (+1.56%)

Is $1,250 next? 🤔

*LONG or SHORT? Comment fast! 👇*

#LLYUSDT #EliLilly #StockTrading #Binance #LLY #Crypto #Trading #Bullish #BinanceSquare #perp

$LLYB
LLYB/USDT LONG SETUP

LLYB is trading around $1,151.78, down 3.59% today. Price has pulled back sharply from the $1,190+ area and is now testing the important $1,133–$1,145 support zone.

I would avoid chasing the drop. The better setup is to wait for support to hold and for a bullish 15m/1h confirmation.

Entry Zone
EP1: $1,145–$1,153
EP2: $1,135–$1,142

Take Profit
TP1: $1,165
TP2: $1,180
TP3: $1,198
TP4: $1,215

Stop Loss: $1,125

#LLYB #LLY #EliLilly #BinanceSquare #Write2Earn $BTC
$ASMLB

$LLYB is the tokenized bStock linked to Eli Lilly (NYSE: LLY). Binance launched LLYB/USDT Spot trading on October 7, 2026, making it a very new market with active price discovery.
💰 Price: ~$1,197.13 📈 24H Change: +2.52% 📊 24H Volume: ~$2.9M 🏦 Market Cap: ~$1.3M 📍 24H Range: $1,164.79–$1,211.32
📈 MARKET VIEW
LLYB is currently showing positive short-term momentum, with price trading close to its recent 24H high. Strong trading volume is also notable for such a new listing.
The underlying Eli Lilly stock gained 2.70% in the latest session, which provides important context for LLYB’s current movement.
🔎 KEY LEVELS TO WATCH • $1,211 area — recent 24H high • $1,165 area — recent 24H low • Volume — important for confirming whether the current momentum continues
#LLYB #EliLilly #Binance #BStocks #TokenizedAssets

My process for the $LLY price action is unglamorous. I do not predict where it goes. I check the calendar for Eli Lilly earnings and any trial or FDA dates, then decide whether I even want leveraged exposure into that window.

On the LLYUSDT perpetual, the danger is not being wrong on direction, it is being oversized when the price gaps and funding stacks up against you. So I read price action to size down, not to call tops or bottoms.

I keep leverage modest, set my stop first, and size for the volatility I can actually see. Been using Bitunix for this exposure and I factor funding into every hold. Not a guarantee, just discipline.

Plan the risk before the trade. Not advice.

$LLY #EliLilly #FuturesTrading #RiskManagement

#EliLillyRises5.3%ToRecordHigh

A stock reaching a record high can attract momentum traders—but new highs are not automatically safe entry points.
Eli Lilly’s reported 5.3% rise shows how quickly capital can rotate into strong sectors and companies. The same momentum psychology appears in crypto markets.

Web3 Research Analyst View
A research analyst should examine whether the move is supported by:
Earnings growth.
Revenue expectations.
Institutional ownership.
Valuation expansion.
Sector-wide strength.
Sustainable trading volume.
Price alone cannot explain whether momentum is healthy.

Trader Survival Plan
Do not FOMO into an asset after a large vertical move. Wait for consolidation, identify the breakout level, and calculate downside before entering.
For crypto traders, the lesson is transferable: strong narratives attract late buyers, and late buyers often become exit liquidity when momentum slows.
Trade the structure—not the excitement.
Is this sustainable accumulation, or momentum chasing at elevated levels?

#EliLilly #MomentumTrading #MarketResearch #RiskManagement
$LLY

$BTC
$BOME

#EliLillyRises5.3%ToRecordHigh

Eli Lilly reportedly rose 5.3% to reach a new record high, showing continued strength in the healthcare sector.
New highs often attract momentum traders, but they can also increase the risk of profit-taking and sharp pullbacks.
The key is not simply whether an asset reaches a record high—it is whether buyers can defend the breakout afterward.
This lesson applies to stocks, crypto, and every momentum market.
Strong trends deserve respect, but risk management should never be ignored.
Are record highs a sign of further strength or a warning to stay cautious?

$AKAM.US
$SKHYB

#EliLilly #Stocks #MomentumTrading #MarketAnalysis

📊 JPMORGAN UPDATES ITS FAVORITE STOCK LIST FOR AUGUST 💼

JPMorgan renewed its monthly selection of key stocks for August, removing Cheniere Energy and Targa Resources 📉.

The bank kept the core of its list, highlighting Walmart as a growth value focused on consumer spending—despite a 16% decline over three months due to moderately paced fiscal outlooks—and Eli Lilly 💊, whose share price has gained 39% since its Q1 26 report.

The market is awaiting the pharmaceutical manufacturer’s quarterly results on August 5 📅.

#JPMorgan #Acciones #Walmart #EliLilly #WallStreet
$BTC
$SOL
$BNB